CTRI/2016/09/007263
Completed
未知
A Randomized Prospective Investigator Blinded study of Bowel Preparation for Colonoscopy with Magnesium Sulphate versus Polyethylene Glycol at a single centre.
Dr Naresh Bhat0 sites120 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Dr Naresh Bhat
- Enrollment
- 120
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All patients who are required to undergo colonoscopy
Exclusion Criteria
- •Multiple comorbidities\-CVA/ACS
- •Renal failure on Dialysis
- •Bowel obstruction
- •Sick patient in ICU
- •Major suergy for colon
- •Age more than 70 yrs
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A randomised, investigator and subject blinded, placebo-controlled study to determine the safety, tolerability, and pharmacokinetics of INF904 in healthy subjects after single and multiple ascending dosesNL-OMON53655InflaRx GmbH86
Active, not recruiting
Phase 1
Clinical Study to Assess the Mode of Action of QBW251 in Patients With Chronic Obstructive Pulmonary Disease (COPD)EUCTR2019-000325-49-DEovartis Pharma AG100
Active, not recruiting
Phase 1
Clinical Study to Assess the Mode of Action of QBW251 in Patients With Chronic Obstructive Pulmonary Disease (COPD)EUCTR2019-000325-49-GBovartis Pharma AG100
Active, not recruiting
Phase 1
A study to assess different investigational drugs for the treatment of hidradenitis suppurativaHidradenitis suppurativaMedDRA version: 20.0Level: LLTClassification code 10020041Term: Hidradenitis suppurativaSystem Organ Class: 100000004858Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]EUCTR2018-002757-30-BEovartis Pharma AG200
Active, not recruiting
Phase 1
A study to assess different investigational drugs for the treatment of hidradenitis suppurativaEUCTR2018-002757-30-FRovartis Pharma AG90